Literature DB >> 9464216

Side effects of short-term 10,000-lux light therapy.

A O Kogan1, P M Guilford.   

Abstract

OBJECTIVE: Previous reports of side effects from light therapy were mostly based on administration of 2,500-lux treatments. It has become common practice to use brighter, 10,000-lux exposure when treating seasonal affective disorder. The authors studied side effects produced by short-term 10,000-lux light therapy.
METHOD: Seventy subjects with seasonal affective disorder who underwent brief 10,000-lux light therapy were asked to report side effects.
RESULTS: Of the 70 subjects, 32 (45.7%) experienced side effects, and nine (12.9%) reported two or more apiece. Headaches and eye or vision problems were the most common. Almost all were mild, were transient, and did not interfere with treatment.
CONCLUSIONS: Short-term 10,000-lux light therapy often produces side effects early in treatment. These are not serious or prolonged, however, confirming findings from earlier studies that used dimmer light.

Entities:  

Mesh:

Year:  1998        PMID: 9464216     DOI: 10.1176/ajp.155.2.293

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

1.  [The current state of research in bright light therapy].

Authors:  Daniela Bassa; Markus Canazei; Hartmann Hinterhuber; Elisabeth M Weiss
Journal:  Neuropsychiatr       Date:  2013-06-21

2.  Light as Therapy for Sleep Disorders and Depression in Older Adults.

Authors:  Philip D Sloane; Mariana Figueiro; Lauren Cohen
Journal:  Clin Geriatr       Date:  2008-03-01

3.  Are short (blue) wavelengths necessary for light treatment of seasonal affective disorder?

Authors:  J L Anderson; M A St Hilaire; R R Auger; C A Glod; S J Crow; A N Rivera; S M Fuentes Salgado; S J Pullen; T K Kaufman; A J Selby; D J Wolfe
Journal:  Chronobiol Int       Date:  2016-08-05       Impact factor: 2.877

4.  The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.

Authors:  Jianhua Shen; Sidney H Kennedy; Robert D Levitan; Leonid Kayumov; Colin M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2005-01       Impact factor: 6.186

5.  Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Aleksandar Videnovic; Elizabeth B Klerman; Wei Wang; Angelica Marconi; Teresa Kuhta; Phyllis C Zee
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

6.  Effects of dynamic bedroom lighting on measures of sleep and circadian rest-activity rhythm in inpatients with major depressive disorder.

Authors:  Markus Canazei; Johannes Weninger; Wilfried Pohl; Josef Marksteiner; Elisabeth M Weiss
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

7.  Bright light in elderly subjects with nonseasonal major depressive disorder: a double blind randomised clinical trial using early morning bright blue light comparing dim red light treatment.

Authors:  Ritsaert Lieverse; Marjan M A Nielen; Dick J Veltman; Bernard M J Uitdehaag; Eus J W van Someren; Jan H Smit; Witte J G Hoogendijk
Journal:  Trials       Date:  2008-07-31       Impact factor: 2.279

8.  Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial.

Authors:  Annelies Brouwer; Daniël H van Raalte; Michaela Diamant; Femke Rutters; Eus J W van Someren; Frank J Snoek; Aartjan T F Beekman; Marijke A Bremmer
Journal:  BMC Psychiatry       Date:  2015-07-24       Impact factor: 3.630

9.  Bright light therapy in Parkinson's disease: an overview of the background and evidence.

Authors:  Sonja Rutten; Chris Vriend; Odile A van den Heuvel; Jan H Smit; Henk W Berendse; Ysbrand D van der Werf
Journal:  Parkinsons Dis       Date:  2012-12-23

10.  The acute side effects of bright light therapy: a placebo-controlled investigation.

Authors:  Yevgeny Botanov; Stephen S Ilardi
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.